Physician

Ashish Ashvin Shah, D.O.

According to 2025 Medicare claims, Ashish Shah, D.O. (NPI: 1285820274) practices hematology/oncology in the Allentown-Bethlehem-Easton, PA-NJ market, with the plurality of this provider's patient population coming from Warren, NJ. This provider's primary affiliated billing organization is PRACTICE ASSOCIATES MEDICAL GROUP (NPI: 1427016385; TIN: 202088165) and primary practice location at 07840-1782. Shah is affiliated with the Atlantic ACO (ACO ID: A1026), participating under the MSSP model.

Shah's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 748 traditional Medicare patients, billed 2,463 HCPCS/CPT codes, and received $196,070 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 254 prescription claims across 72 beneficiaries totaling $974,205 in drug costs, led by Venclexta (Venetoclax). Open Payments data shows 158 records totaling $84,686. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $80,653 to $196,070. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $377,416 and ending at $974,205. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	399	955	$80,653
2016	437	1,198	$90,673
2017	435	2,257	$156,156
2018	476	2,104	$156,851
2019	580	1,810	$161,911
2020	736	2,126	$199,119
2021	735	2,384	$255,665
2022	806	2,295	$246,948
2023	804	3,586	$236,445
2024	748	2,463	$196,070

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	140	831	$377,416
2016	116	509	$615,147
2017	62	389	$452,295
2018	73	537	$497,181
2019	109	536	$343,103
2020	156	644	$1,219,787
2021	127	502	$973,639
2022	94	388	$455,336
2023	83	375	$386,189
2024	72	254	$974,205

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	222	401	$151
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	204	221	$145
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	171	278	$105
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	273	505	$72
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	111	179	$66

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Venclexta	Venetoclax	45	1,346	$586,074
Eliquis	Apixaban	17	630	$12,220
Valacyclovir	Valacyclovir Hcl	20	840	$882
Omeprazole	Omeprazole	28	1,080	$299
Letrozole	Letrozole	14	1,200	$238

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	158	$84,686	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ashish Ashvin Shah, D.O.?

Tedicare shows public-source Medicare data for Ashish Ashvin Shah, D.O. (NPI 1285820274), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ashish Ashvin Shah, D.O. have ACO affiliation data?

Ashish Ashvin Shah, D.O. is shown with ACO affiliation data for Atlantic ACO (MSSP, ACO ID A1026).

What billing organization is linked to Ashish Ashvin Shah, D.O.?

Ashish Ashvin Shah, D.O. is linked to PRACTICE ASSOCIATES MEDICAL GROUP (billing NPI 1427016385) in the available physician profile data.

Does Ashish Ashvin Shah, D.O. have Open Payments data?

Ashish Ashvin Shah, D.O. has 158 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.